REFERENCES
- Lieberman J S. Asthma mortality: the worldwide response. J R Soc Med 1997; 90: 265–267, [INFOTRIEVE], [CSA]
- Sears M R. Epidemiology of asthma. Lancet 1997; 350: 1015–1020, [INFOTRIEVE], [CSA], [CROSSREF]
- Kuehr J, Frischer T, Meinert R, Barth R, Forster J, Schraub S, Urbanek R, Karmaus W. Mite allergen exposure is a risk for the incidence of specific sensitization. J Allergy Clin Immunol 1994; 94: 44–52, [INFOTRIEVE], [CSA], [CROSSREF]
- Sporik S, Holgate S T, Platts-Mills T AE, Cogswell J J. Exposure to house-dust mite allergens (Der p I) and the development of asthma in children. A prospective study. N Engl J Med 1990; 323: 502–507, [PUBMED], [INFOTRIEVE], [CSA]
- Ross M A, Curtis L, Scheff P A, Hrgorezuk D O, Ramakrishnan V, Wadden R A, Persky Y W. Association of asthma symptoms and severity with indoor bioaerosols. Allergy 2000; 55: 705–711, [INFOTRIEVE], [CSA], [CROSSREF]
- Nelson H S, Szefler S J, Jacobs J, Huss K, Shapiro G, Sternberg A L. The relationships among environmental allergen sensitization, allergen exposure, pulmonary function, and bronchial hyperresponsiveness in the Childhood Asthma Management Program. J Allergy Clin Immunol 1999; 104: 775–785, [INFOTRIEVE], [CSA], [CROSSREF]
- U.S. Centers for Disease Control and Prevention—U.S. Institute of Medicine Report of the Health Effects of indoor mold
- Bobbit R C, Crandall M S, Venkataraman A, Bernstein J A. Characterization of a population presenting with suspected mold-related health effects. Ann Allergy Clin Immunol 2004; Ann Allergy Asthma Immunol 2005; 94: 39–44, [CSA]
- Jaakkola J J, Hwang B F, Jaakkola N. Home dampness and molds, parental atopy, and asthma in childhood: A six-year population-based cohort study. Environ Health Perspect 2005; 113: 357–361, [INFOTRIEVE], [CSA]
- Bornehag C G, Sundell J, Sigsgaard T. Dampness in buildings and health (DBH): Report from an ongoing epidemiological investigation on the association between indoor environmental factors and health effects among children in Sweden. Indoor Air 2004; 14(suppl. 7)59–66, [INFOTRIEVE], [CSA], [CROSSREF]
- Spengler J D, Jaakkola J J, Parise H, Katsnelson B A, Privalova L I, Kosheleva A A. Housing characteristics and children's respiratory health in the Russian Federation. Am J Pub Health 2004; 94: 657–662, [INFOTRIEVE], [CSA]
- Riley R L. Ultraviolet air disinfection for control of respiratory contagion. Architectural design and indoor microbial pollution, R B Kundsin. Oxford University Press, New York 1988; 174–197
- Ko G, First M W, Burge H A. The characterization of upper-room ultraviolet germicidal irradiation in inactivating airborne microorganisms. Environ Health Perspect 2002; 110: 95–101, [INFOTRIEVE], [CSA]
- Marier R L, Nelson T. A ventilation-filtration unit for respiratory isolation. Infect Control Hosp Epidemiol 1993; 14: 700–705, [PUBMED], [INFOTRIEVE], [CSA]
- Riley R L. Nardell Ed. Clearing the Air—The Theory and Application of Ultraviolet Air Disinfection. 1989; 139: 1286–1294, [CSA]
- Nardell E. The Evidence for UVGI Efficacy. Power Prescript 1996; 2: 1, 6, 7[CSA]
- Koller L R. Ultraviolet Radiation. John Wiley & Sons, New York 1952
- Luckiesh M. Applications of Germicidal, Erythemal and Infrared Energy. D. Van Nostrand Co., New York 1946
- Philips. UVGI Catalog and Design Guide. Catalog U.D.C., Netherlands 1985, 628.9
- Glazman M. Apparatus for killing microorganisms”. US Patent No. 6,328,937, 2001
- Menzies D, Popa J, Hanley J A, Rand T, Milton D K. Effect of ultraviolet germicidal lights installed in office ventilation systems on workers' health and well being: Double-blind multiple crossover trial. Lancet 2003; 362: 1785–1791, [INFOTRIEVE], [CSA], [CROSSREF]
- Barnes C, Schreiber K, Pacheco F, Landuyt J, Hu F, Portnoy J. Comparison of outdoor allergenic particles and allergen levels. Ann Allergy Asthma Immunol 2000; 84: 47–54, [INFOTRIEVE], [CSA]
- Jones B, Kenward M G. Two-day short course on the design and analysis of cross-over trials. American Society for Quality Control and the American Statistical Association, Atlantic City, NJ December, 1991, 19–20
- Juniper E F, Howland W C, Roberts N B, Thompson A K, King D R. Measuring quality of life in children with rhinoconjunctivitis. J Allergy Clin Immunol 1998; 101: 163–170, [INFOTRIEVE], [CSA], [CROSSREF]
- Zhang J, Yu C, Noonan G, Reiss T F. Effect of montelukast, a once-daily leukotriene receptor antagonist, on peak Expiratory flow variability. Clin Therapeutics 2002; 24: 574–582, [CSA], [CROSSREF]
- Moy M L, Israel E, Weiss S T, Juniper E F, Dube L, Drazen J M. NHBLI Asthma Clinical Research Network. Clinical predictors of health-related quality of life depend on asthma severity. Am J Resp Crit Care Med 2001; 163: 924–929, [INFOTRIEVE], [CSA]
- Shingo S, Zhang J, Reiss T F. Correlation of airway obstruction and patient-reported endpoints in clinical studies. Eur Respir J 2001; 17: 220–224, [INFOTRIEVE], [CSA], [CROSSREF]
- Leone F T, Mauger E A, Peters S P, Chinchilli V M, Fish J E, Boushey H A, Cherniack R M, Drazen J M, Fahy J V, Ford J, Israel E, Lazarus S C, Lemanske R F, Martin R J, McGeady S J, Sorkness C, Szefler S J. Asthma Clinical Research Network of the National Heart, Lung, and Blood Institute. The utility of peak flow, symptom scores, and beta-agonist use as outcome measures in asthma clinical research. Chest 2001; 119: 1027–1033, [INFOTRIEVE], [CSA], [CROSSREF]
- Putzer H, Werenskiold K, Verfuerth C, Schreckenbach T. Blue light inhibits slime mold differentiation at the mRNA level. EMBO J 1983; 2: 261–267, [INFOTRIEVE], [CSA]
- Wood R A, Johnson E F, Van Natta M L, Chen P H, Eggleston P A. A placebo-controlled trial of a HEPA air cleaner in the treatment of cat allergy. Am J Respir Crit Care Med 1998; 158: 115–120, [INFOTRIEVE], [CSA]